{"id":"methyprylon","rwe":[],"tags":[{"label":"methyprylon","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"GABA-A receptor alpha-1/beta-3/gamma-2","category":"target"},{"label":"GABRA1","category":"gene"},{"label":"GABRB3","category":"gene"},{"label":"GABRG2","category":"gene"},{"label":"N05CE02","category":"atc"},{"label":"Off-Patent","category":"patent"},{"label":"Active","category":"status"},{"label":"Insomnia","category":"indication"},{"label":"Roche","category":"company"}],"phase":"marketed","safety":{},"trials":[],"aliases":[],"company":"Roche","patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=METHYPRYLON","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T03:04:51.483609+00:00"},"timeline":{"url":"https://en.wikipedia.org/wiki/Methyprylon","method":"deterministic","source":"Wikipedia","rawText":"","confidence":0.8,"sourceType":"wikipedia","retrievedAt":"2026-04-20T03:04:59.449314+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T03:04:58.289359+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=METHYPRYLON","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T03:04:58.903204+00:00"},"mechanism.target_chembl":{"url":"","method":"api_direct","source":"ChEMBL mechanism: GABA-A receptor; anion channel positive allosteric modulator","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T03:04:59.448671+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1200790/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T03:04:59.351258+00:00"}},"allNames":"noctan","offLabel":[],"synonyms":["methyprylon","dimerin","methyprylone","noctan","noludar","metiprilone"],"timeline":[],"approvals":[{"date":"","orphan":false,"company":"ROCHE","regulator":"FDA"}],"brandName":"Noctan","ecosystem":[{"indication":"Insomnia","otherDrugs":[{"name":"amobarbital","slug":"amobarbital","company":""},{"name":"choline","slug":"choline","company":""},{"name":"daridorexant","slug":"daridorexant","company":"Idorsia Pharmaceuticals Ltd"},{"name":"diphenhydramine","slug":"diphenhydramine","company":"Mcneil Cons"}],"globalPrevalence":750000000}],"mechanism":{"target":"GABA-A receptor alpha-1/beta-3/gamma-2","novelty":"First-in-class","targets":[{"gene":"GABRA1","source":"DrugCentral","target":"GABA-A receptor alpha-1/beta-3/gamma-2","protein":"Gamma-aminobutyric acid receptor subunit alpha-1"},{"gene":"GABRB3","source":"DrugCentral","target":"GABA-A receptor alpha-1/beta-3/gamma-2","protein":"Gamma-aminobutyric acid receptor subunit beta-3"},{"gene":"GABRG2","source":"DrugCentral","target":"GABA-A receptor alpha-1/beta-3/gamma-2","protein":"Gamma-aminobutyric acid receptor subunit gamma-2"}],"modality":"Small Molecule","drugClass":"methyprylon","explanation":"","oneSentence":"","technicalDetail":"Noctan binds to the GABA-A receptor alpha-1/beta-3/gamma-2 subunits, enhancing the receptor's affinity for GABA, a major inhibitory neurotransmitter in the brain, and modulating the receptor's chloride channel activity, leading to sedative and hypnotic effects."},"_wikipedia":{"url":"https://en.wikipedia.org/wiki/Methyprylon","title":"Methyprylon","extract":"Methyprylon, or Noludar, is a sedative/tranquilizer and hypnotic central nervous system depressant of the piperidinedione derivative chemical class, first developed in the 1940s by Hoffmann-La Roche.\nThis medicine was used for treating insomnia, but is now rarely used as it has been replaced by newer drugs with fewer side effects, such as benzodiazepines."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/1774","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=METHYPRYLON","fields":["publications"],"source":"PubMed/NCBI"},{"id":3,"url":"https://en.wikipedia.org/wiki/Methyprylon","fields":["history","overview"],"source":"Wikipedia"},{"id":4,"url":"https://www.fda.gov/drugs/drug-approvals-and-databases/orange-book-data-files","fields":["patents","exclusivity","genericManufacturers"],"source":"FDA Orange Book"}],"_enrichedAt":"2026-03-30T15:07:31.220696","_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T03:05:01.242405+00:00","fieldsConflicting":1,"overallConfidence":0.8},"biosimilars":[],"competitors":[{"drugName":"glutethimide","drugSlug":"glutethimide","fdaApproval":"1976-10-28","genericCount":6,"patentStatus":"Off-patent — generic available","relationship":"same-class"}],"genericName":"methyprylon","indications":{"approved":[{"name":"Insomnia","source":"DrugCentral","snomedId":193462001,"regulator":"FDA","usPrevalence":70000000,"globalPrevalence":750000000,"prevalenceMethod":"curated","prevalenceSource":"Sleep Medicine Reviews, 2023"}],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"patentStatus":"Off-patent — no active Orange Book patents","relatedDrugs":[{"drugId":"glutethimide","brandName":"glutethimide","genericName":"glutethimide","approvalYear":"1976","relationship":"same-class"}],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"_patentsChecked":true,"crossReferences":{"NUI":"N0000146133","NDDF":"001433","UNII":"CUT48I42ON","VUID":"4017769","CHEBI":"CHEBI:31837","VANDF":"4017769","INN_ID":"287","RXNORM":"204352","UMLSCUI":"C0025840","chemblId":"CHEMBL1200790","ChEMBL_ID":"CHEMBL1200790","KEGG_DRUG":"D01150","DRUGBANK_ID":"DB01107","PUBCHEM_CID":"4162","SNOMEDCT_US":"30964009","IUPHAR_LIGAND_ID":"7238","MESH_SUPPLEMENTAL_RECORD_UI":"C084583"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[{"period":"","companyName":"Roche","relationship":"Original Developer"}],"publicationCount":93,"therapeuticAreas":["Neuroscience"],"atcClassification":{"source":"DrugCentral","atcCode":"N05CE02","allCodes":["N05CE02"]},"biosimilarFilings":[],"originalDeveloper":"Roche","recentPublications":[],"companionDiagnostics":[],"genericManufacturers":0,"_genericFilersChecked":true,"genericManufacturerList":[],"status":"approved","companyName":"Roche","companyId":"roche","modality":"Small molecule","firstApprovalDate":"1982","aiSummary":"","enrichmentLevel":3,"visitCount":1,"regulatoryByCountry":[{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":"ROCHE","brand_name_local":null,"application_number":""},{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"IL","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"SG","regulator":"HSA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AE","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"KR","regulator":"MFDS","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AU","regulator":"TGA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"GB","regulator":"MHRA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T03:05:01.242405+00:00","fieldsConflicting":1,"overallConfidence":0.8},"verificationStatus":"enriching","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":false,"score":1}}